CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Don't think our votes will matter, going by the agenda items...

  1. the4hourworkingweek
    120 Posts.
    lightbulb Created with Sketch. 10
    clock Created with Sketch.
    25/05/21
    21:32
    Post #: 53411410
    Don't think our votes will matter, going by the agenda items from last year. all the major holders will vote yes as it will benefit them as well.

    This is what AFR said - https://www.copyright link/rear-window/creso-pharma-high-on-everblu-capital-20210524-p57ulw

    Creso Pharma high on EverBlu Capital

    Markets reporter and commentator
    May 24, 2021 – 11.50pm

    Creso Pharma’s AGM resolutions released last Friday take us deep into the unusual world of penny pot stocks promoted by paid researchers, online tip sheets, and even the chairman and major shareholder’s own corporate advisory house.

    The medicinal cannabis player is looking to raise funds for an acquisition, clinical trials, and what it calls the ramping up of its nutraceutical division. Fairfax Media

    Creso is co-founded and chaired by Adam Blumenthal who via a holding group named Atlantic Capital owned 14.6 per cent of the group in February.

    Sydneysider Blumenthal is also the chairman of family-run corporate adviser and penny stock fund raiser EverBlu Capital, which scored the role of lead manager in an $18 million capital raising for Creso back in March, with Blumenthal always disclosing his interest in both.

    EverBlu earned a 6 per cent cash fee ($1.08 million) on the raising and Creso is now seeking shareholder approval at its June 24 AGM to issue another 3.6 million shares and 12.6 million options to EverBlu for its work at Blumenthal’s other business Creso.

    Last May EverBlu also received cash and 4.5 million shares for its role as the lead manager of a convertible notes issue to fund manager L1 Capital on behalf of Creso.

    RELATED QUOTES

    Creso Pharma Limited

    $0.140 -9.68%
    May 20May 210.0000.1500.300


    Updated: May 25, 2021 – 9.30pm. Data is 20 mins delayed.

    At its AGM the medicinal cannabis player also wants to issue 10 million shares to its consultant Jorge Wernli, and directors Boaz Wachtel and Dr James Ellingford.

    We previously revealed Ellingford earned his “doctorate in management” , which is also sometimes known as the University of Action Learning. Its parent organisation now appears defunct and was described in 2008 by the Times Educational Supplement as a then unaccredited, nominally British online university based in Vanuatu.

    Others to tip into Creso’s raising at 19¢ include active stock promoter S3 Capital, also known as StocksDigital, which already held some 4.3 million shares or nearly 0.5 per cent of the Creso Pharma register last February. and the latter boasts to readers it entered into Creso in December 2020 at 12¢ per share.




    Last edited by the4hourworkingweek: 25/05/21
    CPH Price at posting: 14.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
NEWS Appliances and furnishings impress - will Harvey Norman be next?
right-arrow Created with Sketch.
AWJ Jeffrey's Find delivered $6.3M in gold sales for August, says Auric
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
IMD IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.